Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Groves

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Ceskoslovenska Farmacie|April 1, 1973
[Importance and significance of particle size in pharmaceutical technology]M J Groves
Bollettino Chimico Farmaceutico|October 1, 1991
Particulate contamination in parenterals: current issuesM J Groves
Journal of Pharmaceutical Sciences|June 1, 1993
Pharmaceutical characterization of Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine used for the treatment of superficial bladder cancerM J Groves
The Journal of Pharmacy and Pharmacology|December 1, 1971
Progress towards a standard to limit particulate contamination in intravenous fluidsM J Groves
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 8, 1998
Fibronectin-binding peptides. I. Isolation and characterization of two unique fibronectin-binding peptides from gelatinX Gao, M J Groves
The Journal of Pharmacy and Pharmacology|February 1, 1995
The use of gelatin microparticles to delay the release of readily water-soluble materialsY Lou, M J Groves
Anticancer Research|January 1, 1997
Activity of a mycobacterial antineoplastic glycan against human breast cancerC Donmez, M J Groves
Pharmaceutical Research|September 1, 1993
Preparation of small gelatin and albumin microparticles by a carbon dioxide atomization processL Oner, M J Groves
Pharmaceutical Research|September 1, 1988
Size characterization of Mycobacterium bovis BCG (Bacillus Calmette Guérin) vaccine, Tice substrainA Zhang, M J Groves
The Journal of Pharmacy and Pharmacology|February 24, 2001
Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tabletsG Xu, M J Groves
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Ceskoslovenska Farmacie|April 1, 1973
[Importance and significance of particle size in pharmaceutical technology]M J Groves
Bollettino Chimico Farmaceutico|October 1, 1991
Particulate contamination in parenterals: current issuesM J Groves
Journal of Pharmaceutical Sciences|June 1, 1993
Pharmaceutical characterization of Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine used for the treatment of superficial bladder cancerM J Groves
The Journal of Pharmacy and Pharmacology|December 1, 1971
Progress towards a standard to limit particulate contamination in intravenous fluidsM J Groves
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 8, 1998
Fibronectin-binding peptides. I. Isolation and characterization of two unique fibronectin-binding peptides from gelatinX Gao, M J Groves
The Journal of Pharmacy and Pharmacology|February 1, 1995
The use of gelatin microparticles to delay the release of readily water-soluble materialsY Lou, M J Groves
Anticancer Research|January 1, 1997
Activity of a mycobacterial antineoplastic glycan against human breast cancerC Donmez, M J Groves
Pharmaceutical Research|September 1, 1993
Preparation of small gelatin and albumin microparticles by a carbon dioxide atomization processL Oner, M J Groves
Pharmaceutical Research|September 1, 1988
Size characterization of Mycobacterium bovis BCG (Bacillus Calmette Guérin) vaccine, Tice substrainA Zhang, M J Groves
The Journal of Pharmacy and Pharmacology|February 24, 2001
Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tabletsG Xu, M J Groves
Pageof 9